Thomas S. Templeman
Net worth: 2 M $ as of 2024-06-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tony Vernon | M | 69 |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY.
Medivation, Inc. /Old/
| 18 years |
| Kim Blickenstaff | M | 71 |
Medivation, Inc. /Old/
| 17 years |
| Kathryn Falberg | F | 63 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 6 years |
| Moses Makunje | M | 46 | 4 years | |
| Stephen Bloch | M | 62 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 15 years |
| Kristen K. Sheppard | F | - | 2 years | |
| Robert Bazemore | M | 56 | 4 years | |
| Carol Stuckley | F | 68 | 3 years | |
| Mathias Hukkelhoven | M | 70 | 2 years | |
| Antoine Yver | M | 66 | 3 years | |
| Gary Hattersley | M | 57 | 5 years | |
| Daniel Welch | M | 66 | 4 years | |
| Karen Anderson | F | 57 | 2 years | |
| Stacy Markel | F | 59 | 5 years | |
| Florina Gordon-Krawchick | F | 42 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 14 years |
| Patrick Yue | M | - | 1 years | |
| Harris Rotman | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Hung | M | 67 |
Medivation, Inc. /Old/
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 15 years |
| Clarence Machado | M | 60 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY.
Medivation, Inc. /Old/
| 23 years |
| Christopher Begley | M | 71 | 8 years | |
| Connie R. Curran | M | 76 | 10 years | |
| Ann Thorell | F | 56 | 1 years | |
| F. Ball | M | 68 | 4 years | |
| Samina Bari | M | - | - | |
| Jennifer Fox | F | 52 | 3 years | |
| Isaac Cheng | M | 49 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 8 years |
| Oleg Nodelman | M | 47 | 2 years | |
| Ed Mathers Mathers | M | 64 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 10 years |
| Aaron Kantoff | M | 29 | 1 years | |
| Terrence Kearney | M | 69 | 7 years | |
| William Dempsey | M | 73 | 4 years | |
| Sumant Ramachandra | M | 55 | 7 years | |
| Lawrence Olanoff | M | 72 | 2 years | |
| Dennis Fenton | M | 72 | 3 years | |
| Pavan Cheruvu | M | 42 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 2 years |
| Jennifer Jarrett | F | 53 |
Medivation, Inc. /Old/
| - |
| Robert M. Califf | M | 72 | 1 years | |
| Stefan J. Cross | M | 51 | 5 years | |
| Ilan Oren | M | 40 | 2 years | |
| Gary Pisano | M | 62 | 1 years | |
| Ash Nijhawan | M | - |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | - |
| Patrick Spine | M | 61 | 2 years | |
| Andrea Ciccolini | F | - | 4 years | |
| Tanya L. Hayes | F | - | 1 years | |
| Stan Bukofzer | M | 67 | 3 years | |
| Eric Floyd | M | 61 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 2 years |
| Thomas G. Moore | M | 72 | 5 years | |
| Geraldine Storton | F | - | 9 years | |
| Andrew Robbins | M | 48 | 5 years | |
| Dakota Gallivan | M | - |
Medivation, Inc. /Old/
| 1 years |
| Lukas Roush | M | - |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 3 years |
| Frederick Mohr | M | - | - | |
| Eric Floyd | M | - | - | |
| Evert Schimmelpennink | M | 52 | 4 years | |
| Barbara Bodem | F | 56 | 2 years | |
| Michelle Doig | F | 50 | 2 years | |
| Sergey Yurasov | M | 55 | 3 years | |
| Lawrence T. Friedhoff | M | 75 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | - |
| David Griss | M | - | 6 years | |
| Neil Ryding | M | 63 | 1 years | |
| Jacqualyn Fouse | M | 62 | - | |
| Joshua D. Hamermesh | M | 51 | - | |
| Lisa V. DeLuca | M | - | - | |
| Karen M. King | F | - | 7 years | |
| Ron Squarer | M | 57 | 5 years | |
| David Endicott | M | 58 | - | |
| David Grainger | M | 58 | 3 years | |
| Frank J. Malinoski | M | - |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | - |
| Daphne Jones | F | 67 | 5 years | |
| Mary Gendron | F | 58 | - | |
| Timothy Oldham | M | - | 5 years | |
| John B. Elliot | M | 72 | 1 years | |
| Francois L. Dubois | M | 70 | 1 years | |
| Jonathan Smith | M | - |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | - |
| Marc Yoskowitz | M | 49 | - | |
| Paul Audhya | M | 51 | 3 years | |
| James Hardy | M | 64 | 3 years | |
| Richard Davies | M | 62 | 3 years | |
| Matthew Stober | M | 57 | - | |
| Shane Ernst | M | - | - | |
| Andrew Knudten | M | - | 3 years | |
| Zena G. Kaufman | F | 67 | 3 years | |
| Javad Shahidi | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 70 | 84.34% |
| United Kingdom | 13 | 15.66% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas S. Templeman
- Personal Network
